Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports - Reuters
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQUkdBem1IX3AtekZzbllhUEZyTU9HQU1RY1AxRF9ZSnNoNlAybXNmcnFnTDZ3X3RJWDQ4bXNlNERLeWlUNy02dFNfQl9BbXBKZmRHVXRpdi1oMXltUF9qNVB2NEQ0WDJJbmdXSDJ6WGJDUzR2c0t6MDVycnhKOWRCckwySkc1SjN6d1FZNWpzZW5nSnRHRWl4M3dtaXNMeGN1d0RuMVJsTjR1R25EYWhsbmR5Rk9ndzdhTzJuVzN4QUg2SFR5cDZPbUxDVHhjVmhWaDlaTGI0Z1NwTUhGTlE?oc=5" target="_blank">Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMCanada's Weston family to buy UK's Boots in $8.9 billion deal - Reuters
Canada's Weston family to buy UK's Boots in $8.9 billion deal Reuters
October 7, 2026 at 04:53 PMMcKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PMMcKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Reuters
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports Reuters
October 5, 2026 at 09:09 PMIntesa's MPS bid set to redraw Italian banking landscape - Reuters
Intesa's MPS bid set to redraw Italian banking landscape Reuters
October 5, 2026 at 06:19 PM